Cargando…
SARS-CoV-2 breakthrough infections in vaccinated kidney transplant recipients: an issue of concern
Autores principales: | Wijtvliet, Veerle, Ledeganck, Kristien, Peeters, Bart, Hellemans, Rachel, Abramowicz, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344889/ https://www.ncbi.nlm.nih.gov/pubmed/34603703 http://dx.doi.org/10.1093/ckj/sfab106 |
Ejemplares similares
-
SARS-CoV-2 mRNA vaccination is not associated with the induction of anti-HLA or non-HLA antibodies
por: Wijtvliet, Veerle P.W.M., et al.
Publicado: (2022) -
Non-invasive Biomarkers of Acute Rejection in Kidney Transplantation: Novel Targets and Strategies
por: Eikmans, Michael, et al.
Publicado: (2019) -
COVID-19 Breakthrough Infections in Vaccinated Kidney Transplant Recipients
por: Zhang, Xiaojing, et al.
Publicado: (2022) -
Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti‐IL2 Receptor Monoclonal Antibodies?
por: Hellemans, R., et al.
Publicado: (2016) -
Osmotic Tubulopathy and Acute Thrombotic Microangiopathy in a Kidney Transplant Recipient With a Breakthrough SARS-CoV-2 Infection
por: Fahim, Peter, et al.
Publicado: (2022)